Insider buying
~$45K5,603 sh @ $7.99
Traded Jun 20, 2025 · filed 4 days later
Since the trade +144.0% · S&P 500 +20.5% · to Nov 19
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Checked for new insider filings 2 min ago
Guides: What is an SEC Form 4 · the transaction codes · who has to file · 10b5-1 plans
Open-market purchases by insiders.
Insider buying
Traded Jun 20, 2025 · filed 4 days later
Since the trade +144.0% · S&P 500 +20.5% · to Nov 19
A major shareholder of Nuvectis Pharma paid $45K out of pocket for Nuvectis Pharma shares.
Lately at Nuvectis Pharma: the stock rose 18% in one session on Nov 6 with press coverage; it reported its results on Nov 4; the stock is 30% below its 12-month high.
Insider buying
Traded Jun 20, 2025 · filed 4 days later
Since the trade −85.0% · S&P 500 +20.5% · to Nov 19
The CEO of Akari Therapeutics paid $12K out of pocket for Akari Therapeutics shares.
Lately at Akari Therapeutics: it reported its results on Nov 12; the stock is down 28% in 30 days.
Insider buying
Traded Jun 23, 2025 · filed 1 day later
Since the trade −18.2% · S&P 500 +19.3% · to Nov 19
The CEO of Dolphin Entertainment paid $4.9K out of pocket for Dolphin Entertainment shares.
Lately at Dolphin Entertainment: it reported its results on Nov 10; the stock is down 7% in 30 days.
Insider buying
Traded Jun 16, 2025 · filed 8 days later
An Alight, Inc. / Delaware director paid $1.1K out of pocket for Alight, Inc. / Delaware shares. 1 other person at Alight, Inc. / Delaware bought some too, in the same month.
Lately at Alight, Inc. / Delaware: the stock rose 26% in one session on Nov 4 around a company release; it reported its results on Nov 3; the stock is up 11% in 30 days.
Traded Jun 23, 2025 · largest single transaction ~$3.3K
Lately at Texas Pacific Land Corporation: the stock fell 13% in one session on Nov 4 around a company release; it reported its results on Nov 4; the stock is down 19% in 30 days.
Jun 23, 2025~$1.1K · 1 sh @ $1,098.70
DetailsOfficial recordJun 23, 2025~$2.2K · 2 sh @ $1,098.70
DetailsOfficial recordJun 23, 2025~$1.1K · 1 sh @ $1,088.01
DetailsOfficial recordJun 23, 2025~$1.1K · 1 sh @ $1,098.70
DetailsInsider buying
Traded Jun 23, 2025 · filed 1 day later
An Oric Pharmaceuticals director paid $13K out of pocket for Oric Pharmaceuticals shares. Shares held went up 5% with this purchase.
Lately at Oric Pharmaceuticals: the stock fell 32% in one session on Oct 26 with press coverage; it reported its results on Nov 16; the stock is down 44% in 30 days.
Insider buying
Traded Jun 20, 2025 · filed 4 days later
Since the trade +39.0% · S&P 500 +20.5% · to Nov 19
Clarus's Executive Chairman paid $3.5K out of pocket for Clarus shares.
Lately at Clarus: the stock rose 18% in one session on Nov 6 around a company release; it reported its results on Nov 5; the stock is up 36% in 30 days.
Insider buying
Traded Mar 3, 2025 · filed 113 days later
Tecogen's VP of Business Development paid $1K out of pocket for Tecogen shares. It was the first purchase in over a year.
Lately at Tecogen: the stock fell 15% in one session on Oct 30; it reported its results on Nov 12; the stock is down 19% in 30 days.
Traded Jun 20 – Jun 23, 2025 · largest single transaction ~$3.7K
Lately at Mdb Capital Holdings, LLC: the stock is down 18% in 30 days.
Jun 23, 2025~$2.8K · 677 sh @ $4.12
DetailsOfficial recordJun 20, 2025~$3.7K · 888 sh @ $4.13
DetailsOfficial recordInsider buying
Traded Jun 13, 2025 · filed 10 days later
Since the trade 0.0% · S&P 500 +19.9% · to Nov 19
A Rezolute director paid $4M out of pocket for Rezolute shares. 3 other people at Rezolute bought some too, in the same month. It was the first purchase in 12 months.
Lately at Rezolute: the stock rose 12% in one session on Nov 17 around a company release; it signed an important agreement on Nov 16; the stock is up 14% in 30 days.
Insider buying
Traded Jun 20, 2025 · filed 3 days later
The CEO of Canton Strategic paid $90K out of pocket for Canton Strategic shares. 2 other people at Canton Strategic bought some too, in the same month. It was the first purchase in 7 months.
Lately at Canton Strategic Holdings: it reported its results on Nov 16; the stock is down 29% in 30 days.
Insider buying
Traded Jun 23, 2025 · filed the same day
Since the trade −94.2% · S&P 500 +19.3% · to Nov 19
The CEO of Moleculin Biotech paid $250K out of pocket for Moleculin Biotech shares. 1 other person at Moleculin Biotech bought some too, in the same month. Shares held went up 995% with this purchase.
Lately at Moleculin Biotech: the stock rose 31% in one session on Oct 27; it reported its results on Nov 16; the stock is up 28% in 30 days.
Insider buying
Traded Jun 20, 2025 · filed 3 days later
A Caris Life Sciences director paid $630K out of pocket for Caris Life Sciences shares. 1 other person at Caris Life Sciences bought some too, in the same month. Shares held went up 23% with this purchase.
Lately at Caris Life Sciences: the stock fell 22% in one session on Nov 5 around a company release; it reported its results on Nov 4; the stock is down 40% in 30 days.
Insider buying
Traded Jun 18, 2025 · filed 5 days later
Since the trade +24.6% · S&P 500 +19.8% · to Nov 19
An Immuneering director paid $63K out of pocket for Immuneering shares. 6 other people at Immuneering bought some too, in the same month. Shares held went up 22% with this purchase.
Lately at Immuneering: it changed a top executive or board member on Nov 9; the stock is down 8% in 30 days.
Jun 23, 2025~$2.2K · 2 sh @ $1,098.70
DetailsOfficial recordJun 23, 2025~$3.3K · 3 sh @ $1,098.70
DetailsOfficial record